ribavirin has been researched along with Psychotic Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Neves, S; Bressan, RA; Galvão, A; Miranda-Scippa, A; Paraná, R; Quarantini, LC | 1 |
Amann, B; Grunze, H; Loeschke, K; Schäfer, M; Schlösser, S; Schmidt, F | 1 |
Himelhoch, S | 1 |
1 trial(s) available for ribavirin and Psychotic Disorders
Article | Year |
---|---|
Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Antiviral Agents; Depressive Disorder, Major; Drug Therapy, Combination; Female; Hepatitis C; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Panic Disorder; Polyethylene Glycols; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Time Factors; Treatment Failure | 2007 |
2 other study(ies) available for ribavirin and Psychotic Disorders
Article | Year |
---|---|
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Psychiatric Status Rating Scales; Psychotic Disorders; Recombinant Proteins; Ribavirin | 2000 |
Hepatitis C virus infection.
Topics: Antiviral Agents; Consensus Development Conferences as Topic; Contraindications; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Psychotic Disorders; Ribavirin | 2001 |